Thermedical

Related Content

Health Canada and the U.S. Food and Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide.
News
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
arrow
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter

August 2, 2018 — Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational ...

Home August 02, 2018
arrow
News
Thermedical Tests RF Electrical Energy to Treat Myocardial Infarctions to Prevent Ventricular Tachycardia

October 28, 2008 – Thermedical said yesterday it received a $3.6 million competing phase two renewal grant from the ...

Home October 27, 2008
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now